Division of Endourology, Department of Urology, Miller School of Medicine, University of Miami, 1400 NW 10th Ave, Ste 509, Miami, FL, 33136, USA,
World J Urol. 2013 Oct;31(5):1105-10. doi: 10.1007/s00345-012-0823-3. Epub 2012 Jan 15.
To identify preoperative factors associated with surgical complications and successful diagnostic renal biopsy in both laparoscopic and percutaneous radiofrequency ablation (RFA) of renal masses in order to help aid in preoperative patient counseling for renal RFA.
We reviewed our Institutional Review Board approved database from November 2001 to January 2011, containing 335 tumors treated with either laparoscopic (LRFA) or percutaneous RFA (CTRFA). Preoperative patient demographics, tumor characteristics, and intraoperative surgical data were collected along with biopsy results and clinicopathologic outcomes.
RFA was performed on 335 renal tumors (124 LRFA, 211 CTRFA). Non-diagnostic biopsy occurred in 18 (5.5%) tumors. Of the 317 procedures performed, 121 complications occurred in 103 (30.7%) procedures. Multivariate analysis only showed CTRFA (vs LRFA) to increase the likelihood of non-diagnostic biopsy (OR 5.1, 95% CI 1.2-22, p = 0.032). Increased tumor size (p = 0.007) and synchronous ablations (p = 0.019) increased the risk for major complications, while decreased surgeon experience (p = 0.003) and tumors close to the collecting system (p = 0.005) increased the risk of any complication.
Preoperative recommendations can be made to patients in the future. We suggest counseling patients that when undergoing RFA, percutaneous approach increases the risk of non-diagnostic biopsy, increased tumor size increases the risk of major complications, having more than 1 tumor ablated increases the risk of a major complication, and tumors close to the collecting system may increase the risk of complications.
确定与腹腔镜和经皮射频消融(RFA)治疗肾肿块相关的手术并发症和成功诊断性肾活检的术前因素,以帮助辅助肾 RFA 的术前患者咨询。
我们回顾了我们机构审查委员会批准的数据库,该数据库包含 2001 年 11 月至 2011 年 1 月期间接受腹腔镜(LRFA)或经皮 RFA(CTRFA)治疗的 335 个肿瘤。收集了术前患者人口统计学、肿瘤特征和术中手术数据以及活检结果和临床病理结果。
对 335 个肾肿瘤(124 个 LRFA,211 个 CTRFA)进行了 RFA。18 个(5.5%)肿瘤的活检结果为非诊断性。在 317 例手术中,121 例手术发生 103 例(30.7%)并发症。多变量分析仅显示 CTRFA(与 LRFA 相比)增加了非诊断性活检的可能性(OR 5.1,95%CI 1.2-22,p=0.032)。肿瘤较大(p=0.007)和同步消融(p=0.019)增加了发生严重并发症的风险,而手术医生经验不足(p=0.003)和肿瘤靠近收集系统(p=0.005)增加了发生任何并发症的风险。
今后可以向患者提出术前建议。我们建议告知患者,在接受 RFA 治疗时,经皮方法增加了非诊断性活检的风险,肿瘤越大,严重并发症的风险越高,消融的肿瘤越多,严重并发症的风险越高,肿瘤越靠近收集系统,并发症的风险越高。